Clinical Trial Update: Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating gefitinib in patients with progressive/metastatic neuroendocrine tumors has completed. The study encompassed several ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrinoma
• Gastrointestinal Carcinoid Tumor
• Glucagonoma
• Insulinoma
• Islet Cell Carcinoma
• Pancreatic Polypeptide Tumor
• Somatostatinoma

Drugs mentioned

• Gefitinib (Iressa) (gefitinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Gastrinoma, Glucagonoma | Phase 2 | Status: COMPLETED